XERS News and Press, Xeris Pharmaceuticals Inc. From 05/08/24

2024-05-08 11:41:28 ET More on Xeris Pharmaceuticals Xeris Biopharma: Checking-In On One Of My 'Top Ideas' Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript Xeris gains as Oppenheimer highlights drug technology Xeris Pharmaceuticals Q4 2023 Earnings Pre...

For development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump and pump systems Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing an...

Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that the C...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris’ Chairman and CEO, will pres...

2024-03-30 01:28:53 ET Summary Xeris Biopharma has not yet achieved cash flow breakeven and may no longer be a "Top Idea" in the Compounding Healthcare Investing Group. Xeris has three approved products and a strong pipeline, with potential for market penetration and revenue growt...

2024-03-28 13:11:15 ET More on Xeris Pharmaceuticals Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript Xeris Biopharma: Speculative Buy, Size Your Position Accordingly Xeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024 Xeris Phar...

2024-03-27 16:50:31 ET Gainers: Athira Pharma  ( ATHA ) +5% . ContextLogic  ( WISH ) +5% . Angi  ( ANGI ) +4% . Xeris Biopharma Holdings ( XERS ) +4% . Inozyme Pharma ( INZY ) +3% . Losers: MillerKnoll ( ...

2024-03-06 12:52:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xeris Biopharma Holdings (NASDAQ: XERS ) just reported results for the fourth quarter of 2023. Xeris Biopharma Holdings reported earnings per share of -10 cents. This met ...

2024-03-06 12:50:02 ET Gainers: Aptorum Group Ltd ( APM ) +736% . BiomX ( PHGE ) +144% . Trxade Health ( MEDS ) +87% . New Horizon Aircraft Ltd ( HOVR ) +69% . Rail Vision Ltd ( RVSN ) +62% . Airship AI Holdings ( AISP ) ...

2024-03-06 12:43:15 ET Xeris Biopharma Holdings Inc. (XERS) Q4 2023 Earnings Conference Call March 6, 2024 8:30 am ET Company Participants Paul Edick - Chairman, Chief Executive Officer Steve Pieper - Chief Financial Officer Allison Wey - Senior Vice President, I...